Archer Materials receives Australian patent for quantum chip

Archer Materials limited has announced that an Australian patent has been granted for its quantum computing qubit processor chip.

The organisation has already received patents in the US, Japan, South Korea, China, the UK and Germany for the 12CQ chip as part of its strategy to develop practical quantum computing in Australia and around the world.

Dr Mohammad Choucair, CEO at Archer Materials told Digital Nation Australia, “Quantum computing has the potential to impact almost every sector dependent on computational power.”

Commenting on the patent he said, “Patent protection in major markets is a central element in Archer’s strategy to develop the 12CQ chip and we are proud to be at the forefront of quantum computing and technology innovation in Australia.”

Archer Materials is the only company on the ASX developing qubit processor chip technology in the semiconductor industry and the company claims that the chip could advance the integration of quantum for consumers and industry alike.

“The advantages of Archer’s 12CQ chip qubit material could pave the way for the integration of quantum processors in mobile devices and an extensive range of consumer and industry electronics,” said a spokesperson.

Archer also recently announced a milestone in their work towards achieving a 10 nanometre (nm) biochip with a successful 15 nanometre (nm) feature size fabrication using lithographic processes.

The company describes the biochip as “lab-on-a-chip technology”, combining device components with biochemical reactions in order to detect complex communicable diseases.

Archer claims that reducing the feature size will allow for billions of sensors on the biochip.

Commenting on the progress, Choucair said, “Archer’s core business is the development of advanced semiconductor technology that is underpinned by the Company’s nanofabrication capabilities.

“Achieving 15 nanometre feature size is a great outcome. We now have prepared a suite of advanced lithography processes to reliably control fabrication for our device miniaturisation and scaling as we continue to advance towards breaking through the 10 nanometre barrier.”